the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C
Clinical trial NCT06132360 · COMPLETED
Trial details
- NCT number
- NCT06132360
- Sponsor
- Shanghai Rona Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-18
- Primary completion
- 2024-07-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.